ABSTRACT
The paper presents a procedure of teleradiotherapy in patients with stages III-IV cancer of the cervix uteri with significant concurrent pathology. Control patients with the similar disease stages underwent combined radiation therapy. If there are contraindications to combined radiation therapy, teleradiotherapy is possible and required as an independent treatment that prolongs and improves the patients' like quality irrespective of the extent of a tumorous process.
Subject(s)
Adenocarcinoma/radiotherapy , Brachytherapy , Carcinoma, Squamous Cell/radiotherapy , Radioisotope Teletherapy , Uterine Cervical Neoplasms/radiotherapy , Adenocarcinoma/mortality , Carcinoma, Squamous Cell/mortality , Cesium Radioisotopes/therapeutic use , Cobalt Radioisotopes/therapeutic use , Female , Humans , Radiotherapy Dosage , Risk Factors , Time Factors , Uterine Cervical Neoplasms/mortalityABSTRACT
The outcomes of radiation treatment of 70 patients with Stage I-II vulvar cancer are analyzed. Combined treatment was used in 10 patients (3 and 7 patients had Stage I and II, respectively), combined radical radiation therapy was applied in 21 patients (Stage II), split-course gamma-teletherapy was employed in 28 patients (6 and 22 patients with Stages II and III, respectively) and 3 females had short-range X-ray therapy. Palliative radiation therapy was performed in 8 patients with Stage III tumors. Complete clinical tumor resolution was achieved in 16 (57%) patients receiving gamma-teletherapy, 15 (71.4%) and in all three women having short-range X-ray therapy. It is recommended that patients with vulvar cancer should receive split-course radiation, which yields good late treatment results and prevents from significant local radiation reactions and complications. Early diagnosis and timely use of combined treatment provide best treatment results in patients with vulvar cancer and in those with other malignant neoplasms.
Subject(s)
Carcinoma, Squamous Cell/radiotherapy , Vulvar Neoplasms/radiotherapy , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/mortality , Female , Follow-Up Studies , Humans , Middle Aged , Neoplasm Staging , Palliative Care , Retrospective Studies , Survival Rate , Treatment Outcome , Vulvar Neoplasms/diagnosis , Vulvar Neoplasms/mortalitySubject(s)
Hodgkin Disease , Lumbar Vertebrae , Spinal Neoplasms/secondary , Thoracic Vertebrae , Diagnosis, Differential , Female , Hodgkin Disease/diagnostic imaging , Hodgkin Disease/pathology , Humans , Lumbar Vertebrae/diagnostic imaging , Male , Radiography , Spinal Neoplasms/diagnostic imaging , Thoracic Vertebrae/diagnostic imaging , Tuberculosis, Spinal/diagnosisABSTRACT
X-Ray diagnosis of secondary involvement of the vertebrae in Hodgkin's disease is difficult because pathognomonic shadow symptoms are absent. Interpretation of roentgenograms is still more difficult when a soft-tissue component which may simulate a "cold abscess" appears in the paravertebral area. Differential diagnosis is based on the clinical and x-ray correlations and histologic findings.
